Respiratory Self-Rescue Intervention for Anesthesia
Trial Summary
What is the purpose of this trial?
This study will explore the feasibility of an idea to use standard, FDA-approved patient monitors to detect ventilatory depression and then play a recorded nurse's voice to prompt patients by name to breathe. The voice prompt will occur in addition to when the traditional alarms are sounded by the monitors. The study device consists of commercially available physiologic monitors, a speaker, and a laptop computer. The physiologic monitors include a pulse oximeter with a motion sensor, capnometer, and nasal airway pressure sensor (built into a nasal cannula). Nasal pressure is a commonly used clinical monitor for sleep apnea detection during polysomnography testing in sleep labs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the study coordinators or your doctor for guidance.
What data supports the effectiveness of the treatment NM3 in the Respiratory Self-Rescue Intervention for Anesthesia trial?
The research highlights the importance of effective airway management and the use of emergency manuals to improve patient safety during anesthesia. These findings suggest that structured interventions and training can enhance the management of respiratory events, which may indirectly support the effectiveness of NM3 in improving outcomes during anesthesia.12345
Is the Respiratory Self-Rescue Intervention for Anesthesia generally safe for humans?
How is the NM3 treatment for anesthesia-related respiratory issues different from other treatments?
The NM3 treatment, as part of the Respiratory Self-Rescue Intervention for Anesthesia, may involve novel approaches like the Lubo Airway Collar, which provides an automated jaw thrust to alleviate upper airway obstruction, making it unique compared to traditional manual methods used in anesthesia-related respiratory issues.1011121314
Research Team
Ken B Johnson, MD
Principal Investigator
University of Utah
Eligibility Criteria
This trial is for patients who will stay in the hospital at least 24 hours after surgery, including those with known or high-risk obstructive sleep apnea (OSA), and nurses caring for these patients. It's not for day-surgery patients, pregnant women, prisoners, or those unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are monitored for ventilatory depression and receive recorded verbal prompts to breathe during the first 24 hours post-surgery
Follow-up
Participants are monitored for safety and effectiveness after the initial 24-hour monitoring period
Treatment Details
Interventions
- NM3
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor